deoxyribose has been researched along with fluorouracil in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Evans, RM; Hakala, MT; Laskin, JD | 1 |
| Bruns, CJ; Doenecke, A; Frank, E; Geissler, EK; Guba, M; Jauch, KW; Koehl, GE; Seeliger, H; Steinbauer, M; Wagner, C | 1 |
| Ahmad, SI | 1 |
3 other study(ies) available for deoxyribose and fluorouracil
| Article | Year |
|---|---|
Effect of excess folates and deoxyinosine on the activity and site of action of 5-fluorouracil.
Topics: Animals; Carcinoma; Cell Line; Deoxyribonucleosides; Deoxyribose; Deoxyuridine; Drug Synergism; Fluorouracil; Humans; Inosine; Leucovorin; Mice; Sarcoma, Experimental; Thymidine; Thymidylate Synthase | 1981 |
Blockage of 2-deoxy-D-ribose-induced angiogenesis with rapamycin counteracts a thymidine phosphorylase-based escape mechanism available for colon cancer under 5-fluorouracil therapy.
Topics: Adenocarcinoma; Animals; Antimetabolites, Antineoplastic; Aorta, Thoracic; Colonic Neoplasms; Deoxyribose; Disease Models, Animal; Fluorouracil; Immunosuppressive Agents; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, SCID; Muscle, Smooth, Vascular; Neovascularization, Pathologic; Rats; Rats, Inbred ACI; Sirolimus; Thymidine Phosphorylase | 2004 |
5-Fluorouracil in combination with deoxyribonucleosides and deoxyribose as possible therapeutic options for the Coronavirus, COVID-19 infection.
Topics: Adenosine Monophosphate; Alanine; Betacoronavirus; Chloroquine; Clinical Trials as Topic; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Deoxyribonucleosides; Deoxyribose; Drug Administration Schedule; Drug Synergism; Fluorouracil; Humans; Inflammation; Models, Theoretical; Pandemics; Pneumonia, Viral; SARS-CoV-2 | 2020 |